Sponsor
NiKang Therapeutics, Inc.
Clinical research sponsor
Clinical trials
3 shownA Study With NKT5097 for Adults With Advanced/Metastatic Solid TumorsNCT07029399 · lead sponsor · 2025-03-25
RECRUITINGA Study With NKT3964 for Adults With Advanced/Metastatic Solid TumorsNCT06586957 · lead sponsor · 2024-09-19
RECRUITINGA Study With NKT3447 for Adults With Advanced/Metastatic Solid TumorsNCT06264921 · lead sponsor · 2024-02-23
TERMINATEDSponsor roles
lead sponsor3
How to interpret this record
CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.